Stockscreener 앱 받기
339.97
0.81%
-2.76
전일 마감가:
$342.73
열려 있는:
$339.76
하루 거래량:
337.81K
Relative Volume:
0.50
시가총액:
$23.93B
수익:
$3.22B
순이익/손실:
$542.70M
주가수익비율:
45.45
EPS:
7.4805
순현금흐름:
$458.00M
1주 성능:
+0.74%
1개월 성능:
-2.52%
6개월 성능:
+36.62%
1년 성능:
+37.34%
1일 변동 폭
$339.76
$342.67
1주일 범위
$335.51
$346.00
52주 변동 폭
$223.83
$386.00
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
339.97 | 24.90B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
366.70 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
184.74 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
70.50 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
228.35 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.59 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity? - Yahoo Finance
Rubber Gaskets Pharmaceutical Containers Market Outlook to 2035 - IndexBox
West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap - Yahoo Finance
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - TradingView
West Pharmaceutical Services stock holds steady as investors eye recent rating and earnings momentum - AD HOC NEWS
West Pharmaceutical (NYSE:WST) Draws Attention As Fair Value Rises - Kalkine Media
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
West Pharmaceutical stock gains on strong Q2 2026 earnings and guidance - AD HOC NEWS
West Pharmaceutical stock holds above $340 as analysts target higher gains - AD HOC NEWS
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical stock holds steady as analysts maintain a moderate buy view - AD HOC NEWS
West Pharmaceutical Services (WST): Investor Outlook with a Promising 19.93% Upside Potential - DirectorsTalk Interviews
Are Wall Street Analysts Predicting West Pharmaceutical Stock Will Climb or Sink? - webull.com
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Inc. (WST) Key Financial Ratios – Valuation, Profitability & More - Value Research
16,794 Shares in West Pharmaceutical Services, Inc. $WST Acquired by Cibc World Market Inc. - MarketBeat
West Pharmaceutical to present at major healthc... - pluang.com
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST) Stock Analysis: Riding a 14.63% Potential Upside with Strong Analyst Confidence - DirectorsTalk Interviews
West Pharmaceutical Services, Inc. (WPS) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical stock holds firm after Q2 beat - Ad-hoc-news.de
NFJ Investment Group LLC Invests $7.76 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Wealthfront Advisers LLC Acquires Shares of 6,440 West Pharmaceutical Services, Inc. $WST - MarketBeat
2,043,823 Shares in West Pharmaceutical Services, Inc. $WST Bought by Bank of New York Mellon Corp - MarketBeat
West Pharmaceutical Services (WST) Gains Momentum On An Undervalued Narrative - Yahoo Finance
West Pharmaceutical stock holds firm as analysts lift targets - Ad-hoc-news.de
Madison Asset Management LLC Invests $9.90 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Makes New $67.58 Million Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
Generation Investment Management LLP Invests $728.17 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
410,699 Shares in West Pharmaceutical Services, Inc. $WST Acquired by Deutsche Bank AG - MarketBeat
BlackRock Inc. Buys Shares of 6,651,784 West Pharmaceutical Services, Inc. $WST - MarketBeat
Join Class Action to Recover Losses from West Pharmaceutical Serv - The National Law Review
West Pharmaceutical stock steadies after institutional buying as shares trade near 52-week highs - Ad-hoc-news.de
Meeder Asset Management Inc. Makes New Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
Pallas Capital Advisors LLC Acquires New Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical's Long-Term Growth Intact - Morningstar
West Pharmaceutical Services (WST): Analyst Consensus And 15.83% Potential Upside - DirectorsTalk Interviews
Is West Pharmaceutical Services (WST) Undervalued After Its Run to $349.42? - Sahm
West Pharmaceutical Services (WST) Holds Above $349 as Shares Edge Higher — Key Levels in FocusMcClellan Summation - vinanet.vn
WST Stock Surges 38.1% Since March-End: What's Fueling the Rally? - Yahoo Finance
West Pharmaceutical (WST) Upgraded to Buy: Here's Why - Yahoo Finance
West Pharmaceutical Services, Inc.: Target Price Consensus and Analysts Recommendations | WST | US9553061055 - marketscreener.com
Zacks Research Has Optimistic Outlook of WST Q3 Earnings - MarketBeat
West Pharmaceutical Services (NYSE:WST) Rating Lowered to Hold at Zacks Research - MarketBeat
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Should Investors Buy WST as HVP Growth Meets a Premium Valuation? - TradingView
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
West Pharmaceutical Services Inc 주식 (WST) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Favorite Annette F | Sr. VP & Chief HR Officer |
Apr 27 '26 |
Option Exercise |
83.47 |
2,817 |
235,135 |
19,645 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Apr 27 '26 |
Sale |
305.20 |
2,817 |
859,753 |
16,828 |
| Winters Chad | VP, Chief Accounting Officer |
Apr 27 '26 |
Option Exercise |
173.22 |
896 |
155,205 |
2,419 |
| Winters Chad | VP, Chief Accounting Officer |
Apr 27 '26 |
Sale |
300.67 |
896 |
269,399 |
1,523 |
0.00%
0.81%
자본화:
|
볼륨(24시간):